nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—ABCB1—ovarian cancer	0.254	1	CbGaD
Fluvoxamine—CYP3A7—Paclitaxel—ovarian cancer	0.0405	0.09	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0405	0.09	CbGbCtD
Fluvoxamine—ABCB1—Topotecan—ovarian cancer	0.04	0.0888	CbGbCtD
Fluvoxamine—CYP3A5—Paclitaxel—ovarian cancer	0.0304	0.0675	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0293	0.0651	CbGbCtD
Fluvoxamine—CYP3A7—Docetaxel—ovarian cancer	0.0293	0.0651	CbGbCtD
Fluvoxamine—ABCB1—Vinorelbine—ovarian cancer	0.0282	0.0625	CbGbCtD
Fluvoxamine—CYP2D6—Vinorelbine—ovarian cancer	0.0265	0.0589	CbGbCtD
Fluvoxamine—CYP3A4—Topotecan—ovarian cancer	0.024	0.0532	CbGbCtD
Fluvoxamine—CYP3A5—Docetaxel—ovarian cancer	0.022	0.0488	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—ovarian cancer	0.0208	0.0462	CbGbCtD
Fluvoxamine—CYP2C9—Paclitaxel—ovarian cancer	0.0204	0.0453	CbGbCtD
Fluvoxamine—ABCB1—Paclitaxel—ovarian cancer	0.0198	0.0439	CbGbCtD
Fluvoxamine—CYP3A4—Vinorelbine—ovarian cancer	0.0169	0.0375	CbGbCtD
Fluvoxamine—ABCB1—Docetaxel—ovarian cancer	0.0143	0.0318	CbGbCtD
Fluvoxamine—CYP3A4—Paclitaxel—ovarian cancer	0.0119	0.0263	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—ovarian cancer	0.0107	0.0237	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—ovarian cancer	0.0101	0.0223	CbGbCtD
Fluvoxamine—CYP3A4—Docetaxel—ovarian cancer	0.00857	0.019	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—ovarian cancer	0.00639	0.0142	CbGbCtD
Fluvoxamine—SIGMAR1—myometrium—ovarian cancer	0.000273	0.0537	CbGeAlD
Fluvoxamine—SIGMAR1—uterine cervix—ovarian cancer	0.000213	0.0418	CbGeAlD
Fluvoxamine—SIGMAR1—decidua—ovarian cancer	0.000203	0.0398	CbGeAlD
Fluvoxamine—SIGMAR1—endometrium—ovarian cancer	0.000192	0.0378	CbGeAlD
Fluvoxamine—SIGMAR1—uterus—ovarian cancer	0.000177	0.0348	CbGeAlD
Fluvoxamine—SLC6A4—female reproductive system—ovarian cancer	0.00016	0.0315	CbGeAlD
Fluvoxamine—SIGMAR1—bone marrow—ovarian cancer	0.00015	0.0295	CbGeAlD
Fluvoxamine—SIGMAR1—female gonad—ovarian cancer	0.000145	0.0285	CbGeAlD
Fluvoxamine—CYP1A1—epithelium—ovarian cancer	0.000144	0.0283	CbGeAlD
Fluvoxamine—SIGMAR1—vagina—ovarian cancer	0.000144	0.0283	CbGeAlD
Fluvoxamine—CYP1A1—uterine cervix—ovarian cancer	0.000143	0.0281	CbGeAlD
Fluvoxamine—SLC6A3—testis—ovarian cancer	0.000141	0.0277	CbGeAlD
Fluvoxamine—CYP3A5—uterine cervix—ovarian cancer	0.00014	0.0274	CbGeAlD
Fluvoxamine—SIGMAR1—testis—ovarian cancer	0.000129	0.0253	CbGeAlD
Fluvoxamine—CYP2C19—vagina—ovarian cancer	0.00012	0.0236	CbGeAlD
Fluvoxamine—CYP1A1—uterus—ovarian cancer	0.000119	0.0234	CbGeAlD
Fluvoxamine—CYP2B6—gonad—ovarian cancer	0.000117	0.0229	CbGeAlD
Fluvoxamine—Dysuria—Doxorubicin—ovarian cancer	0.000109	0.000422	CcSEcCtD
Fluvoxamine—Decreased appetite—Paclitaxel—ovarian cancer	0.000109	0.000422	CcSEcCtD
Fluvoxamine—Dry mouth—Docetaxel—ovarian cancer	0.000108	0.00042	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000108	0.00042	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000108	0.000419	CcSEcCtD
Fluvoxamine—Fatigue—Paclitaxel—ovarian cancer	0.000108	0.000419	CcSEcCtD
Fluvoxamine—Sweating—Epirubicin—ovarian cancer	0.000108	0.000417	CcSEcCtD
Fluvoxamine—Pollakiuria—Doxorubicin—ovarian cancer	0.000108	0.000417	CcSEcCtD
Fluvoxamine—Constipation—Paclitaxel—ovarian cancer	0.000107	0.000415	CcSEcCtD
Fluvoxamine—Pain—Paclitaxel—ovarian cancer	0.000107	0.000415	CcSEcCtD
Fluvoxamine—Haematuria—Epirubicin—ovarian cancer	0.000107	0.000415	CcSEcCtD
Fluvoxamine—Confusional state—Docetaxel—ovarian cancer	0.000107	0.000415	CcSEcCtD
Fluvoxamine—CYP1A1—female reproductive system—ovarian cancer	0.000107	0.021	CbGeAlD
Fluvoxamine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000107	0.000412	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000106	0.000412	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000106	0.000411	CcSEcCtD
Fluvoxamine—Oedema—Docetaxel—ovarian cancer	0.000106	0.000411	CcSEcCtD
Fluvoxamine—Weight increased—Doxorubicin—ovarian cancer	0.000106	0.000411	CcSEcCtD
Fluvoxamine—Epistaxis—Epirubicin—ovarian cancer	0.000106	0.00041	CcSEcCtD
Fluvoxamine—Infection—Docetaxel—ovarian cancer	0.000106	0.000409	CcSEcCtD
Fluvoxamine—Weight decreased—Doxorubicin—ovarian cancer	0.000106	0.000409	CcSEcCtD
Fluvoxamine—Sinusitis—Epirubicin—ovarian cancer	0.000105	0.000408	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000105	0.000407	CcSEcCtD
Fluvoxamine—Agranulocytosis—Epirubicin—ovarian cancer	0.000105	0.000406	CcSEcCtD
Fluvoxamine—Pneumonia—Doxorubicin—ovarian cancer	0.000105	0.000405	CcSEcCtD
Fluvoxamine—Shock—Docetaxel—ovarian cancer	0.000105	0.000405	CcSEcCtD
Fluvoxamine—Nervous system disorder—Docetaxel—ovarian cancer	0.000104	0.000403	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000104	0.000403	CcSEcCtD
Fluvoxamine—CYP2B6—female reproductive system—ovarian cancer	0.000104	0.0204	CbGeAlD
Fluvoxamine—Drowsiness—Doxorubicin—ovarian cancer	0.000104	0.000403	CcSEcCtD
Fluvoxamine—Tachycardia—Docetaxel—ovarian cancer	0.000104	0.000402	CcSEcCtD
Fluvoxamine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000103	0.0004	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000103	0.000399	CcSEcCtD
Fluvoxamine—CYP2C9—female reproductive system—ovarian cancer	0.000103	0.0202	CbGeAlD
Fluvoxamine—Bradycardia—Epirubicin—ovarian cancer	0.000103	0.000398	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000103	0.000397	CcSEcCtD
Fluvoxamine—Renal failure—Doxorubicin—ovarian cancer	0.000102	0.000396	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000102	0.000395	CcSEcCtD
Fluvoxamine—Haemoglobin—Epirubicin—ovarian cancer	0.000101	0.000393	CcSEcCtD
Fluvoxamine—Stomatitis—Doxorubicin—ovarian cancer	0.000101	0.000392	CcSEcCtD
Fluvoxamine—Jaundice—Doxorubicin—ovarian cancer	0.000101	0.000392	CcSEcCtD
Fluvoxamine—Anorexia—Docetaxel—ovarian cancer	0.000101	0.000392	CcSEcCtD
Fluvoxamine—Rhinitis—Epirubicin—ovarian cancer	0.000101	0.000392	CcSEcCtD
Fluvoxamine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000101	0.000391	CcSEcCtD
Fluvoxamine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000101	0.000391	CcSEcCtD
Fluvoxamine—Haemorrhage—Epirubicin—ovarian cancer	0.000101	0.000391	CcSEcCtD
Fluvoxamine—Hepatitis—Epirubicin—ovarian cancer	0.000101	0.000391	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Epirubicin—ovarian cancer	0.0001	0.000389	CcSEcCtD
Fluvoxamine—Pharyngitis—Epirubicin—ovarian cancer	0.0001	0.000388	CcSEcCtD
Fluvoxamine—Sweating—Doxorubicin—ovarian cancer	9.97e-05	0.000386	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Epirubicin—ovarian cancer	9.97e-05	0.000386	CcSEcCtD
Fluvoxamine—Urticaria—Paclitaxel—ovarian cancer	9.97e-05	0.000386	CcSEcCtD
Fluvoxamine—Oedema peripheral—Epirubicin—ovarian cancer	9.94e-05	0.000385	CcSEcCtD
Fluvoxamine—Hypotension—Docetaxel—ovarian cancer	9.93e-05	0.000384	CcSEcCtD
Fluvoxamine—Haematuria—Doxorubicin—ovarian cancer	9.92e-05	0.000384	CcSEcCtD
Fluvoxamine—Abdominal pain—Paclitaxel—ovarian cancer	9.92e-05	0.000384	CcSEcCtD
Fluvoxamine—Body temperature increased—Paclitaxel—ovarian cancer	9.92e-05	0.000384	CcSEcCtD
Fluvoxamine—Urethral disorder—Epirubicin—ovarian cancer	9.89e-05	0.000383	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Doxorubicin—ovarian cancer	9.84e-05	0.000381	CcSEcCtD
Fluvoxamine—Epistaxis—Doxorubicin—ovarian cancer	9.81e-05	0.00038	CcSEcCtD
Fluvoxamine—CYP2E1—female reproductive system—ovarian cancer	9.77e-05	0.0192	CbGeAlD
Fluvoxamine—Sinusitis—Doxorubicin—ovarian cancer	9.76e-05	0.000378	CcSEcCtD
Fluvoxamine—CYP1A1—female gonad—ovarian cancer	9.75e-05	0.0191	CbGeAlD
Fluvoxamine—Visual impairment—Epirubicin—ovarian cancer	9.73e-05	0.000376	CcSEcCtD
Fluvoxamine—Agranulocytosis—Doxorubicin—ovarian cancer	9.71e-05	0.000376	CcSEcCtD
Fluvoxamine—CYP1A1—vagina—ovarian cancer	9.69e-05	0.019	CbGeAlD
Fluvoxamine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	9.69e-05	0.000375	CcSEcCtD
Fluvoxamine—Insomnia—Docetaxel—ovarian cancer	9.62e-05	0.000372	CcSEcCtD
Fluvoxamine—Paraesthesia—Docetaxel—ovarian cancer	9.55e-05	0.000369	CcSEcCtD
Fluvoxamine—Erythema multiforme—Epirubicin—ovarian cancer	9.54e-05	0.000369	CcSEcCtD
Fluvoxamine—ABCB1—myometrium—ovarian cancer	9.54e-05	0.0187	CbGeAlD
Fluvoxamine—CYP3A5—female gonad—ovarian cancer	9.53e-05	0.0187	CbGeAlD
Fluvoxamine—Bradycardia—Doxorubicin—ovarian cancer	9.51e-05	0.000368	CcSEcCtD
Fluvoxamine—Dyspnoea—Docetaxel—ovarian cancer	9.48e-05	0.000367	CcSEcCtD
Fluvoxamine—CYP3A5—vagina—ovarian cancer	9.47e-05	0.0186	CbGeAlD
Fluvoxamine—Somnolence—Docetaxel—ovarian cancer	9.45e-05	0.000366	CcSEcCtD
Fluvoxamine—Eye disorder—Epirubicin—ovarian cancer	9.43e-05	0.000365	CcSEcCtD
Fluvoxamine—CYP2B6—vagina—ovarian cancer	9.41e-05	0.0185	CbGeAlD
Fluvoxamine—Tinnitus—Epirubicin—ovarian cancer	9.41e-05	0.000364	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—ovarian cancer	9.39e-05	0.000363	CcSEcCtD
Fluvoxamine—Cardiac disorder—Epirubicin—ovarian cancer	9.37e-05	0.000363	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—ovarian cancer	9.36e-05	0.000362	CcSEcCtD
Fluvoxamine—Dyspepsia—Docetaxel—ovarian cancer	9.36e-05	0.000362	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—ovarian cancer	9.34e-05	0.000361	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—ovarian cancer	9.34e-05	0.000361	CcSEcCtD
Fluvoxamine—SIGMAR1—lymph node—ovarian cancer	9.32e-05	0.0183	CbGeAlD
Fluvoxamine—Hypoaesthesia—Doxorubicin—ovarian cancer	9.29e-05	0.00036	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—ovarian cancer	9.27e-05	0.000359	CcSEcCtD
Fluvoxamine—Decreased appetite—Docetaxel—ovarian cancer	9.24e-05	0.000358	CcSEcCtD
Fluvoxamine—Hypersensitivity—Paclitaxel—ovarian cancer	9.24e-05	0.000358	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—ovarian cancer	9.22e-05	0.000357	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—ovarian cancer	9.2e-05	0.000356	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Docetaxel—ovarian cancer	9.18e-05	0.000355	CcSEcCtD
Fluvoxamine—ABCB1—embryo—ovarian cancer	9.18e-05	0.018	CbGeAlD
Fluvoxamine—Fatigue—Docetaxel—ovarian cancer	9.17e-05	0.000355	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—ovarian cancer	9.16e-05	0.000354	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—ovarian cancer	9.16e-05	0.000354	CcSEcCtD
Fluvoxamine—Pain—Docetaxel—ovarian cancer	9.09e-05	0.000352	CcSEcCtD
Fluvoxamine—Constipation—Docetaxel—ovarian cancer	9.09e-05	0.000352	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—ovarian cancer	9.06e-05	0.00035	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—ovarian cancer	9.02e-05	0.000349	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—ovarian cancer	9e-05	0.000348	CcSEcCtD
Fluvoxamine—Asthenia—Paclitaxel—ovarian cancer	9e-05	0.000348	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—ovarian cancer	8.92e-05	0.000345	CcSEcCtD
Fluvoxamine—Pruritus—Paclitaxel—ovarian cancer	8.87e-05	0.000343	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—ovarian cancer	8.84e-05	0.000342	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—ovarian cancer	8.83e-05	0.000342	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—ovarian cancer	8.79e-05	0.00034	CcSEcCtD
Fluvoxamine—Feeling abnormal—Docetaxel—ovarian cancer	8.76e-05	0.000339	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—ovarian cancer	8.73e-05	0.000338	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—ovarian cancer	8.71e-05	0.000337	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Docetaxel—ovarian cancer	8.69e-05	0.000336	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—ovarian cancer	8.67e-05	0.000335	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—ovarian cancer	8.66e-05	0.000335	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—ovarian cancer	8.62e-05	0.000334	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—ovarian cancer	8.6e-05	0.000333	CcSEcCtD
Fluvoxamine—Diarrhoea—Paclitaxel—ovarian cancer	8.58e-05	0.000332	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—ovarian cancer	8.53e-05	0.00033	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—ovarian cancer	8.5e-05	0.000329	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—ovarian cancer	8.47e-05	0.000328	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—ovarian cancer	8.45e-05	0.000327	CcSEcCtD
Fluvoxamine—Abdominal pain—Docetaxel—ovarian cancer	8.4e-05	0.000325	CcSEcCtD
Fluvoxamine—Body temperature increased—Docetaxel—ovarian cancer	8.4e-05	0.000325	CcSEcCtD
Fluvoxamine—CYP2B6—testis—ovarian cancer	8.4e-05	0.0165	CbGeAlD
Fluvoxamine—Chills—Doxorubicin—ovarian cancer	8.38e-05	0.000324	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—ovarian cancer	8.34e-05	0.000323	CcSEcCtD
Fluvoxamine—Dizziness—Paclitaxel—ovarian cancer	8.29e-05	0.000321	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—ovarian cancer	8.28e-05	0.00032	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—ovarian cancer	8.25e-05	0.000319	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—ovarian cancer	8.18e-05	0.000317	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—ovarian cancer	8.15e-05	0.000316	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—ovarian cancer	8.13e-05	0.000315	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—ovarian cancer	8.12e-05	0.000314	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—ovarian cancer	8.07e-05	0.000312	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—ovarian cancer	8.01e-05	0.00031	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—ovarian cancer	7.98e-05	0.000309	CcSEcCtD
Fluvoxamine—Vomiting—Paclitaxel—ovarian cancer	7.98e-05	0.000309	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—ovarian cancer	7.96e-05	0.000308	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—ovarian cancer	7.92e-05	0.000307	CcSEcCtD
Fluvoxamine—Rash—Paclitaxel—ovarian cancer	7.91e-05	0.000306	CcSEcCtD
Fluvoxamine—Dermatitis—Paclitaxel—ovarian cancer	7.9e-05	0.000306	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—ovarian cancer	7.9e-05	0.000306	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—ovarian cancer	7.89e-05	0.000306	CcSEcCtD
Fluvoxamine—CYP2E1—testis—ovarian cancer	7.88e-05	0.0155	CbGeAlD
Fluvoxamine—Syncope—Epirubicin—ovarian cancer	7.88e-05	0.000305	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—ovarian cancer	7.87e-05	0.000304	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—ovarian cancer	7.86e-05	0.000304	CcSEcCtD
Fluvoxamine—CYP3A4—female reproductive system—ovarian cancer	7.86e-05	0.0154	CbGeAlD
Fluvoxamine—Headache—Paclitaxel—ovarian cancer	7.86e-05	0.000304	CcSEcCtD
Fluvoxamine—Hypersensitivity—Docetaxel—ovarian cancer	7.83e-05	0.000303	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—ovarian cancer	7.82e-05	0.000302	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—ovarian cancer	7.77e-05	0.0003	CcSEcCtD
Fluvoxamine—CYP2D6—female reproductive system—ovarian cancer	7.73e-05	0.0152	CbGeAlD
Fluvoxamine—Loss of consciousness—Epirubicin—ovarian cancer	7.72e-05	0.000299	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—ovarian cancer	7.67e-05	0.000297	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—ovarian cancer	7.66e-05	0.000297	CcSEcCtD
Fluvoxamine—Asthenia—Docetaxel—ovarian cancer	7.63e-05	0.000295	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—ovarian cancer	7.61e-05	0.000295	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—ovarian cancer	7.59e-05	0.000294	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—ovarian cancer	7.54e-05	0.000292	CcSEcCtD
Fluvoxamine—Pruritus—Docetaxel—ovarian cancer	7.52e-05	0.000291	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—ovarian cancer	7.51e-05	0.000291	CcSEcCtD
Fluvoxamine—ABCB1—epithelium—ovarian cancer	7.49e-05	0.0147	CbGeAlD
Fluvoxamine—Arthralgia—Epirubicin—ovarian cancer	7.48e-05	0.000289	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—ovarian cancer	7.48e-05	0.000289	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—ovarian cancer	7.48e-05	0.000289	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—ovarian cancer	7.47e-05	0.000289	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—ovarian cancer	7.45e-05	0.000288	CcSEcCtD
Fluvoxamine—Nausea—Paclitaxel—ovarian cancer	7.45e-05	0.000288	CcSEcCtD
Fluvoxamine—ABCB1—uterine cervix—ovarian cancer	7.43e-05	0.0146	CbGeAlD
Fluvoxamine—Discomfort—Epirubicin—ovarian cancer	7.39e-05	0.000286	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—ovarian cancer	7.33e-05	0.000284	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—ovarian cancer	7.32e-05	0.000283	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—ovarian cancer	7.3e-05	0.000283	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—ovarian cancer	7.29e-05	0.000282	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—ovarian cancer	7.28e-05	0.000282	CcSEcCtD
Fluvoxamine—Diarrhoea—Docetaxel—ovarian cancer	7.27e-05	0.000282	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—ovarian cancer	7.23e-05	0.00028	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—ovarian cancer	7.18e-05	0.000278	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—ovarian cancer	7.17e-05	0.000278	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—ovarian cancer	7.17e-05	0.000278	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—ovarian cancer	7.15e-05	0.000277	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—ovarian cancer	7.12e-05	0.000276	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—ovarian cancer	7.09e-05	0.000275	CcSEcCtD
Fluvoxamine—ABCB1—decidua—ovarian cancer	7.07e-05	0.0139	CbGeAlD
Fluvoxamine—Shock—Epirubicin—ovarian cancer	7.06e-05	0.000273	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—ovarian cancer	7.04e-05	0.000273	CcSEcCtD
Fluvoxamine—CYP2D6—female gonad—ovarian cancer	7.04e-05	0.0138	CbGeAlD
Fluvoxamine—Nervous system disorder—Epirubicin—ovarian cancer	7.03e-05	0.000272	CcSEcCtD
Fluvoxamine—Dizziness—Docetaxel—ovarian cancer	7.03e-05	0.000272	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—ovarian cancer	7.02e-05	0.000272	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—ovarian cancer	7.02e-05	0.000272	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—ovarian cancer	7e-05	0.000271	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—ovarian cancer	6.93e-05	0.000268	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—ovarian cancer	6.92e-05	0.000268	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—ovarian cancer	6.92e-05	0.000268	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—ovarian cancer	6.92e-05	0.000268	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—ovarian cancer	6.9e-05	0.000267	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—ovarian cancer	6.84e-05	0.000265	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—ovarian cancer	6.84e-05	0.000265	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—ovarian cancer	6.77e-05	0.000262	CcSEcCtD
Fluvoxamine—Vomiting—Docetaxel—ovarian cancer	6.76e-05	0.000262	CcSEcCtD
Fluvoxamine—ABCB1—endometrium—ovarian cancer	6.72e-05	0.0132	CbGeAlD
Fluvoxamine—Rash—Docetaxel—ovarian cancer	6.7e-05	0.000259	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—ovarian cancer	6.7e-05	0.000259	CcSEcCtD
Fluvoxamine—Dermatitis—Docetaxel—ovarian cancer	6.7e-05	0.000259	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—ovarian cancer	6.69e-05	0.000259	CcSEcCtD
Fluvoxamine—Headache—Docetaxel—ovarian cancer	6.66e-05	0.000258	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—ovarian cancer	6.64e-05	0.000257	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—ovarian cancer	6.64e-05	0.000257	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—ovarian cancer	6.59e-05	0.000255	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.53e-05	0.000253	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—ovarian cancer	6.53e-05	0.000253	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—ovarian cancer	6.51e-05	0.000252	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—ovarian cancer	6.5e-05	0.000251	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—ovarian cancer	6.49e-05	0.000251	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—ovarian cancer	6.48e-05	0.000251	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—ovarian cancer	6.44e-05	0.000249	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—ovarian cancer	6.41e-05	0.000248	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—ovarian cancer	6.39e-05	0.000247	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—ovarian cancer	6.38e-05	0.000247	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—ovarian cancer	6.33e-05	0.000245	CcSEcCtD
Fluvoxamine—Nausea—Docetaxel—ovarian cancer	6.32e-05	0.000244	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—ovarian cancer	6.31e-05	0.000244	CcSEcCtD
Fluvoxamine—CYP1A1—lymph node—ovarian cancer	6.27e-05	0.0123	CbGeAlD
Fluvoxamine—CYP2D6—testis—ovarian cancer	6.24e-05	0.0123	CbGeAlD
Fluvoxamine—Decreased appetite—Epirubicin—ovarian cancer	6.23e-05	0.000241	CcSEcCtD
Fluvoxamine—ABCB1—gonad—ovarian cancer	6.23e-05	0.0122	CbGeAlD
Fluvoxamine—Hypotension—Doxorubicin—ovarian cancer	6.2e-05	0.00024	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.19e-05	0.00024	CcSEcCtD
Fluvoxamine—ABCB1—uterus—ovarian cancer	6.19e-05	0.0122	CbGeAlD
Fluvoxamine—Fatigue—Epirubicin—ovarian cancer	6.18e-05	0.000239	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—ovarian cancer	6.13e-05	0.000237	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—ovarian cancer	6.13e-05	0.000237	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.05e-05	0.000234	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—ovarian cancer	6e-05	0.000232	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—ovarian cancer	5.96e-05	0.000231	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—ovarian cancer	5.92e-05	0.000229	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—ovarian cancer	5.91e-05	0.000229	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—ovarian cancer	5.9e-05	0.000228	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—ovarian cancer	5.86e-05	0.000227	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—ovarian cancer	5.84e-05	0.000226	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—ovarian cancer	5.77e-05	0.000223	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.73e-05	0.000222	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—ovarian cancer	5.72e-05	0.000221	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—ovarian cancer	5.7e-05	0.00022	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—ovarian cancer	5.67e-05	0.00022	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—ovarian cancer	5.67e-05	0.00022	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—ovarian cancer	5.67e-05	0.000219	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—ovarian cancer	5.67e-05	0.000219	CcSEcCtD
Fluvoxamine—ABCB1—female reproductive system—ovarian cancer	5.56e-05	0.0109	CbGeAlD
Fluvoxamine—Feeling abnormal—Doxorubicin—ovarian cancer	5.47e-05	0.000212	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.43e-05	0.00021	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—ovarian cancer	5.28e-05	0.000204	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—ovarian cancer	5.27e-05	0.000204	CcSEcCtD
Fluvoxamine—ABCB1—bone marrow—ovarian cancer	5.25e-05	0.0103	CbGeAlD
Fluvoxamine—Abdominal pain—Doxorubicin—ovarian cancer	5.25e-05	0.000203	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—ovarian cancer	5.25e-05	0.000203	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—ovarian cancer	5.15e-05	0.000199	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—ovarian cancer	5.07e-05	0.000196	CcSEcCtD
Fluvoxamine—ABCB1—female gonad—ovarian cancer	5.06e-05	0.00994	CbGeAlD
Fluvoxamine—ABCB1—vagina—ovarian cancer	5.03e-05	0.00988	CbGeAlD
Fluvoxamine—Diarrhoea—Epirubicin—ovarian cancer	4.91e-05	0.00019	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—ovarian cancer	4.89e-05	0.000189	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—ovarian cancer	4.76e-05	0.000184	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—ovarian cancer	4.74e-05	0.000184	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—ovarian cancer	4.69e-05	0.000182	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—ovarian cancer	4.56e-05	0.000176	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—ovarian cancer	4.54e-05	0.000176	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—ovarian cancer	4.52e-05	0.000175	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—ovarian cancer	4.52e-05	0.000175	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—ovarian cancer	4.49e-05	0.000174	CcSEcCtD
Fluvoxamine—ABCB1—testis—ovarian cancer	4.49e-05	0.00882	CbGeAlD
Fluvoxamine—Dizziness—Doxorubicin—ovarian cancer	4.39e-05	0.00017	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—ovarian cancer	4.26e-05	0.000165	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—ovarian cancer	4.22e-05	0.000163	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—ovarian cancer	4.18e-05	0.000162	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—ovarian cancer	4.18e-05	0.000162	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—ovarian cancer	4.16e-05	0.000161	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—ovarian cancer	3.94e-05	0.000153	CcSEcCtD
Fluvoxamine—ABCB1—lymph node—ovarian cancer	3.25e-05	0.00639	CbGeAlD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.05e-05	0.000639	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYTB—ovarian cancer	2.02e-05	0.000632	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYTB—ovarian cancer	2.02e-05	0.00063	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYTB—ovarian cancer	1.91e-05	0.000596	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.89e-05	0.00059	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NME2—ovarian cancer	1.89e-05	0.000589	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.87e-05	0.000585	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.87e-05	0.000582	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—BRIP1—ovarian cancer	1.81e-05	0.000564	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPP1CC—ovarian cancer	1.81e-05	0.000564	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.77e-05	0.000554	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPP1CC—ovarian cancer	1.77e-05	0.000552	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—BRIP1—ovarian cancer	1.77e-05	0.000552	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.77e-05	0.000551	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.77e-05	0.000551	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—MAPK1—ovarian cancer	1.69e-05	0.000529	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.68e-05	0.000523	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—BRIP1—ovarian cancer	1.67e-05	0.000521	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPP1CC—ovarian cancer	1.67e-05	0.000521	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.64e-05	0.000513	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—YAP1—ovarian cancer	1.64e-05	0.000511	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.6e-05	0.0005	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYTB—ovarian cancer	1.56e-05	0.000487	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.53e-05	0.000477	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.53e-05	0.000477	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.53e-05	0.000476	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYTB—ovarian cancer	1.52e-05	0.000476	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.52e-05	0.000475	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.49e-05	0.000466	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.48e-05	0.000461	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NME2—ovarian cancer	1.46e-05	0.000455	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.45e-05	0.000453	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.44e-05	0.000449	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYTB—ovarian cancer	1.44e-05	0.000448	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYTB—ovarian cancer	1.42e-05	0.000444	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.4e-05	0.000438	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.39e-05	0.000434	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.36e-05	0.000426	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.36e-05	0.000426	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—HRAS—ovarian cancer	1.36e-05	0.000424	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—FASN—ovarian cancer	1.34e-05	0.000417	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.33e-05	0.000416	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—BRIP1—ovarian cancer	1.33e-05	0.000416	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.31e-05	0.00041	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.31e-05	0.000408	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.27e-05	0.000396	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.27e-05	0.000395	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.26e-05	0.000392	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.26e-05	0.000392	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.24e-05	0.000388	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.24e-05	0.000388	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYTB—ovarian cancer	1.22e-05	0.00038	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.22e-05	0.00038	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.22e-05	0.000379	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—YAP1—ovarian cancer	1.21e-05	0.000378	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.2e-05	0.000374	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.19e-05	0.000371	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—YAP1—ovarian cancer	1.19e-05	0.00037	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—YAP1—ovarian cancer	1.18e-05	0.00037	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.17e-05	0.000364	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.14e-05	0.000356	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.14e-05	0.000356	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—YAP1—ovarian cancer	1.12e-05	0.000349	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.11e-05	0.000346	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.08e-05	0.000337	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.08e-05	0.000336	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.06e-05	0.000332	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.06e-05	0.000332	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ABCB1—ovarian cancer	1e-05	0.000313	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.95e-06	0.00031	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.89e-06	0.000309	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—FASN—ovarian cancer	9.88e-06	0.000308	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—TYMS—ovarian cancer	9.84e-06	0.000307	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.73e-06	0.000304	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	9.71e-06	0.000303	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—FASN—ovarian cancer	9.67e-06	0.000302	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—FASN—ovarian cancer	9.65e-06	0.000301	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.57e-06	0.000299	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	9.51e-06	0.000297	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SLC5A5—ovarian cancer	9.5e-06	0.000296	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYTB—ovarian cancer	9.39e-06	0.000293	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	9.38e-06	0.000293	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	9.19e-06	0.000287	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SLC2A1—ovarian cancer	9.17e-06	0.000286	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—YAP1—ovarian cancer	9.15e-06	0.000286	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—FASN—ovarian cancer	9.12e-06	0.000285	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.07e-06	0.000283	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.06e-06	0.000283	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	8.99e-06	0.000281	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SLC5A5—ovarian cancer	8.97e-06	0.00028	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—YAP1—ovarian cancer	8.94e-06	0.000279	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	8.81e-06	0.000275	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP1B1—ovarian cancer	8.79e-06	0.000274	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SLC2A1—ovarian cancer	8.66e-06	0.00027	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.48e-06	0.000265	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—YAP1—ovarian cancer	8.42e-06	0.000263	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—YAP1—ovarian cancer	8.35e-06	0.000261	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP1B1—ovarian cancer	8.31e-06	0.000259	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.26e-06	0.000258	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	8.21e-06	0.000256	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—BRIP1—ovarian cancer	8.21e-06	0.000256	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.08e-06	0.000252	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	7.98e-06	0.000249	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.96e-06	0.000249	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CAV1—ovarian cancer	7.93e-06	0.000247	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	7.81e-06	0.000244	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	7.8e-06	0.000243	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.75e-06	0.000242	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—FASN—ovarian cancer	7.46e-06	0.000233	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ABCB1—ovarian cancer	7.41e-06	0.000231	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	7.37e-06	0.00023	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	7.34e-06	0.000229	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.33e-06	0.000229	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—FASN—ovarian cancer	7.28e-06	0.000227	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TYMS—ovarian cancer	7.27e-06	0.000227	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.26e-06	0.000227	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ABCB1—ovarian cancer	7.25e-06	0.000226	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ABCB1—ovarian cancer	7.24e-06	0.000226	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CG—ovarian cancer	7.22e-06	0.000225	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.16e-06	0.000224	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—YAP1—ovarian cancer	7.13e-06	0.000223	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TYMS—ovarian cancer	7.13e-06	0.000222	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TYMS—ovarian cancer	7.11e-06	0.000222	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	7.09e-06	0.000221	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.06e-06	0.00022	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.94e-06	0.000217	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.92e-06	0.000216	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—FASN—ovarian cancer	6.86e-06	0.000214	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCB1—ovarian cancer	6.84e-06	0.000213	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—FASN—ovarian cancer	6.8e-06	0.000212	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	6.8e-06	0.000212	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	6.75e-06	0.000211	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TYMS—ovarian cancer	6.72e-06	0.00021	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.69e-06	0.000209	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.63e-06	0.000207	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	6.52e-06	0.000204	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.46e-06	0.000202	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CD—ovarian cancer	6.35e-06	0.000198	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.33e-06	0.000198	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	6.25e-06	0.000195	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.21e-06	0.000194	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	6.2e-06	0.000193	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	6.03e-06	0.000188	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6e-06	0.000187	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.88e-06	0.000184	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAV1—ovarian cancer	5.86e-06	0.000183	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—FASN—ovarian cancer	5.81e-06	0.000182	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAV1—ovarian cancer	5.74e-06	0.000179	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAV1—ovarian cancer	5.73e-06	0.000179	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	5.72e-06	0.000179	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCB1—ovarian cancer	5.6e-06	0.000175	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	5.54e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CB—ovarian cancer	5.53e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	5.52e-06	0.000172	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—YAP1—ovarian cancer	5.51e-06	0.000172	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TYMS—ovarian cancer	5.5e-06	0.000172	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.5e-06	0.000172	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.47e-06	0.000171	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAV1—ovarian cancer	5.41e-06	0.000169	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.41e-06	0.000169	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TYMS—ovarian cancer	5.37e-06	0.000167	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	5.34e-06	0.000167	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	5.3e-06	0.000165	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	5.23e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CG—ovarian cancer	5.22e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.17e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCB1—ovarian cancer	5.15e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCB1—ovarian cancer	5.1e-06	0.000159	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TYMS—ovarian cancer	5.06e-06	0.000158	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TYMS—ovarian cancer	5.01e-06	0.000156	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CG—ovarian cancer	4.93e-06	0.000154	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTEN—ovarian cancer	4.78e-06	0.000149	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.7e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	4.69e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.67e-06	0.000146	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	4.6e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	4.59e-06	0.000143	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—FASN—ovarian cancer	4.49e-06	0.00014	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAV1—ovarian cancer	4.43e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.41e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCB1—ovarian cancer	4.36e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CD—ovarian cancer	4.33e-06	0.000135	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAV1—ovarian cancer	4.32e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TYMS—ovarian cancer	4.28e-06	0.000134	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.26e-06	0.000133	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.23e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	4.09e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.09e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAV1—ovarian cancer	4.07e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAV1—ovarian cancer	4.04e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	4.03e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	4.01e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4e-06	0.000125	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.94e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.86e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CB—ovarian cancer	3.78e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.71e-06	0.000116	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.68e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.63e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.55e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTEN—ovarian cancer	3.54e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTEN—ovarian cancer	3.46e-06	0.000108	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.46e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTEN—ovarian cancer	3.46e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAV1—ovarian cancer	3.45e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	3.37e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.37e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TYMS—ovarian cancer	3.31e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.3e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTEN—ovarian cancer	3.26e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.26e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.23e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.14e-06	9.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.09e-06	9.65e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.02e-06	9.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.84e-06	8.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.82e-06	8.8e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.76e-06	8.63e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—ovarian cancer	2.76e-06	8.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTEN—ovarian cancer	2.67e-06	8.34e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.66e-06	8.31e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTEN—ovarian cancer	2.61e-06	8.14e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.49e-06	7.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.46e-06	7.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.44e-06	7.62e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.44e-06	7.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTEN—ovarian cancer	2.44e-06	7.6e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.43e-06	7.57e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.41e-06	7.52e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—ovarian cancer	2.3e-06	7.19e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.13e-06	6.66e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTEN—ovarian cancer	2.08e-06	6.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—ovarian cancer	2.04e-06	6.36e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—ovarian cancer	2e-06	6.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—ovarian cancer	1.99e-06	6.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.88e-06	5.88e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—ovarian cancer	1.88e-06	5.87e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.86e-06	5.8e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.84e-06	5.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.73e-06	5.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.72e-06	5.36e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.61e-06	5.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—ovarian cancer	1.54e-06	4.81e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—ovarian cancer	1.5e-06	4.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.47e-06	4.58e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.42e-06	4.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.4e-06	4.38e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.2e-06	3.74e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.13e-06	3.54e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—ovarian cancer	9.26e-07	2.89e-05	CbGpPWpGaD
